Redox responsive cyclodextrin-based drug delivery systems: a special insight to glutathione responsive CD-nanosponges
Glutathione-responsive cyclodextrin nanosponges (CDNSs) exploit intracellular redox gradients via disulfide bond cleavage, enabling selective drug release in cancerous and inflammatory